-
Reducing the Transmission and Annual Burden of Influenza in the UK With Baloxavir Marboxil: A Cost-Effectiveness Analysis Using Evidence From the CENTERSTONE Trial
Sep 9, 2025, 16:22 PM -
European and US Drug Shortages: A Critical Analysis of Key Trends and Causes
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Funding the Fight Against Antimicrobial Resistance: Learnings From the UK and Sweden’s Pilot Incentive Programs
Sep 9, 2025, 16:22 PM -
Knowledge and Attitudes Regarding the HPV Vaccine Among Secondary School Students
Sep 9, 2025, 16:22 PM -
The Economic Burden of Moderate and Severe Anxiety and Depression Symptoms in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Incidence and Treatment of Squamous-Cell Anal Cancer (SCAC) in Germany: A Retrospective Study in German Statutory Health Insurance (SHI) Claims Data
Sep 9, 2025, 16:22 PM -
Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada
Sep 9, 2025, 16:22 PM -
Real-World Cost-Utility of Faricimab vs. Current and Future Anti-VEGF Therapies in Patients With Neovascular Age-Related Macular Degeneration in Italy
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
Quantifying the Value of Information in Early Stage Health Technology Assessment: Guiding Investment in Evidence Generation
Sep 9, 2025, 16:22 PM -
Are Real-World Survival Outcomes in Metastatic Breast Cancer Transportable Between the US and Austria?
Sep 9, 2025, 16:22 PM -
Multicriteria Health Technology Assessments for High-Cost Oncology Drugs in Peru: A Cross-Sectional Study of RENETSA Records 2023-2024
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Does Proposed IRP Introduction in the US Align With Current IRP Trends and With Best Practice Guidelines?
Sep 9, 2025, 16:22 PM -
The Cost of Inaction: Strengthening Nutrition in Frailty Guidelines Across Europe
Sep 9, 2025, 16:22 PM -
Importance of Decisional Context in the Health Technology Assessment (HTA) of Ultra-Orphan Drugs
Sep 9, 2025, 16:22 PM -
Use of Big Data to Assess Dyslipidemia Management in Greece: Real-World Insights From the National Healthcare Payer
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
A Systematic Literature Review on Costs and Healthcare Resource Utilization in Spinal Muscular Atrophy
Sep 9, 2025, 16:22 PM
